<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-31" modified="2020-10-07" version="147">
<accession>Q8TD43</accession>
<accession>A2RU25</accession>
<accession>Q7Z5D9</accession>
<accession>Q96L84</accession>
<accession>Q9NXV1</accession>
<name>TRPM4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transient receptor potential cation channel subfamily M member 4</fullName>
<shortName>hTRPM4</shortName>
</recommendedName>
<alternativeName>
<fullName>Calcium-activated non-selective cation channel 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Long transient receptor potential channel 4</fullName>
<shortName>LTrpC-4</shortName>
<shortName>LTrpC4</shortName>
</alternativeName>
<alternativeName>
<fullName>Melastatin-4</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="37">TRPM4</name>
<name type="synonym">LTRPC4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="10692" last="10697">
<title>Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform.</title>
<authorList>
<person name="Xu X.-Z.S."/>
<person name="Moebius F."/>
<person name="Gill D.L."/>
<person name="Montell C."/>
</authorList>
<dbReference type="PubMed" id="11535825"/>
<dbReference type="DOI" id="10.1073/pnas.191360198"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Cell" volume="109" first="397" last="407">
<title>TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization.</title>
<authorList>
<person name="Launay P."/>
<person name="Fleig A."/>
<person name="Perraud A.-L."/>
<person name="Scharenberg A.M."/>
<person name="Penner R."/>
<person name="Kinet J.-P."/>
</authorList>
<dbReference type="PubMed" id="12015988"/>
<dbReference type="DOI" id="10.1016/s0092-8674(02)00719-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Curr. Biol." volume="13" first="1153" last="1158">
<title>TRPM5 is a voltage-modulated and Ca(2+)-activated monovalent selective cation channel.</title>
<authorList>
<person name="Hofmann T."/>
<person name="Chubanov V."/>
<person name="Gudermann T."/>
<person name="Montell C."/>
</authorList>
<dbReference type="PubMed" id="12842017"/>
<dbReference type="DOI" id="10.1016/s0960-9822(03)00431-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30813" last="30820">
<title>Voltage dependence of the Ca2+-activated cation channel TRPM4.</title>
<authorList>
<person name="Nilius B."/>
<person name="Prenen J."/>
<person name="Droogmans G."/>
<person name="Voets T."/>
<person name="Vennekens R."/>
<person name="Freichel M."/>
<person name="Wissenbach U."/>
<person name="Flockerzi V."/>
</authorList>
<dbReference type="PubMed" id="12799367"/>
<dbReference type="DOI" id="10.1074/jbc.m305127200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="42728" last="42728">
<authorList>
<person name="Nilius B."/>
<person name="Prenen J."/>
<person name="Droogmans G."/>
<person name="Voets T."/>
<person name="Vennekens R."/>
<person name="Freichel M."/>
<person name="Wissenbach U."/>
<person name="Flockerzi V."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:12799367</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Circ. Res." volume="95" first="922" last="929">
<title>Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries.</title>
<authorList>
<person name="Earley S."/>
<person name="Waldron B.J."/>
<person name="Brayden J.E."/>
</authorList>
<dbReference type="PubMed" id="15472118"/>
<dbReference type="DOI" id="10.1161/01.res.0000147311.54833.03"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Physiol. (Lond.)" volume="558" first="75" last="83">
<title>Functional characterization of a Ca(2+)-activated non-selective cation channel in human atrial cardiomyocytes.</title>
<authorList>
<person name="Guinamard R."/>
<person name="Chatelier A."/>
<person name="Demion M."/>
<person name="Potreau D."/>
<person name="Patri S."/>
<person name="Rahmati M."/>
<person name="Bois P."/>
</authorList>
<dbReference type="PubMed" id="15121803"/>
<dbReference type="DOI" id="10.1113/jphysiol.2004.063974"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Physiol. (Lond.)" volume="560" first="753" last="765">
<title>Decavanadate modulates gating of TRPM4 cation channels.</title>
<authorList>
<person name="Nilius B."/>
<person name="Prenen J."/>
<person name="Janssens A."/>
<person name="Voets T."/>
<person name="Droogmans G."/>
</authorList>
<dbReference type="PubMed" id="15331675"/>
<dbReference type="DOI" id="10.1113/jphysiol.2004.070839"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Pflugers Arch." volume="448" first="70" last="75">
<title>Intracellular nucleotides and polyamines inhibit the Ca2+-activated cation channel TRPM4b.</title>
<authorList>
<person name="Nilius B."/>
<person name="Prenen J."/>
<person name="Voets T."/>
<person name="Droogmans G."/>
</authorList>
<dbReference type="PubMed" id="14758478"/>
<dbReference type="DOI" id="10.1007/s00424-003-1221-x"/>
</citation>
<scope>ATP-BINDING</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Science" volume="306" first="1374" last="1377">
<title>TRPM4 regulates calcium oscillations after T cell activation.</title>
<authorList>
<person name="Launay P."/>
<person name="Cheng H."/>
<person name="Srivatsan S."/>
<person name="Penner R."/>
<person name="Fleig A."/>
<person name="Kinet J.-P."/>
</authorList>
<dbReference type="PubMed" id="15550671"/>
<dbReference type="DOI" id="10.1126/science.1098845"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="6423" last="6433">
<title>Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4.</title>
<authorList>
<person name="Nilius B."/>
<person name="Prenen J."/>
<person name="Tang J."/>
<person name="Wang C."/>
<person name="Owsianik G."/>
<person name="Janssens A."/>
<person name="Voets T."/>
<person name="Zhu M.X."/>
</authorList>
<dbReference type="PubMed" id="15590641"/>
<dbReference type="DOI" id="10.1074/jbc.m411089200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-1145 AND SER-1152</scope>
<scope>ATP-BINDING</scope>
<scope>CALMODULIN-BINDING</scope>
<scope>MUTAGENESIS OF LEU-275; ILE-278; ASP-279; GLY-324; GLY-325; ARG-327; SER-1145 AND SER-1152</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="22899" last="22906">
<title>The selectivity filter of the cation channel TRPM4.</title>
<authorList>
<person name="Nilius B."/>
<person name="Prenen J."/>
<person name="Janssens A."/>
<person name="Owsianik G."/>
<person name="Wang C."/>
<person name="Zhu M.X."/>
<person name="Voets T."/>
</authorList>
<dbReference type="PubMed" id="15845551"/>
<dbReference type="DOI" id="10.1074/jbc.m501686200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLN-977; GLU-981; 981-GLU--ALA-986; ASP-982 AND ASP-984</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="39185" last="39192">
<title>Phosphatidylinositol 4,5-bisphosphate rescues TRPM4 channels from desensitization.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Okawa H."/>
<person name="Wang Y."/>
<person name="Liman E.R."/>
</authorList>
<dbReference type="PubMed" id="16186107"/>
<dbReference type="DOI" id="10.1074/jbc.m506965200"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>PIP2-BINDING</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Cell Calcium" volume="41" first="51" last="61">
<title>TRPM4 controls insulin secretion in pancreatic beta-cells.</title>
<authorList>
<person name="Cheng H."/>
<person name="Beck A."/>
<person name="Launay P."/>
<person name="Gross S.A."/>
<person name="Stokes A.J."/>
<person name="Kinet J.-P."/>
<person name="Fleig A."/>
<person name="Penner R."/>
</authorList>
<dbReference type="PubMed" id="16806463"/>
<dbReference type="DOI" id="10.1016/j.ceca.2006.04.032"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="467" last="478">
<title>The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate.</title>
<authorList>
<person name="Nilius B."/>
<person name="Mahieu F."/>
<person name="Prenen J."/>
<person name="Janssens A."/>
<person name="Owsianik G."/>
<person name="Vennekens R."/>
<person name="Voets T."/>
</authorList>
<dbReference type="PubMed" id="16424899"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600963"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PIP2-BINDING</scope>
<scope>MUTAGENESIS OF LYS-1059; ARG-1072 AND 1136-ARG--ARG-1141</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="J. Recept. Signal Transduct." volume="26" first="159" last="178">
<title>Tissue distribution profiles of the human TRPM cation channel family.</title>
<authorList>
<person name="Fonfria E."/>
<person name="Murdock P.R."/>
<person name="Cusdin F.S."/>
<person name="Benham C.D."/>
<person name="Kelsell R.E."/>
<person name="McNulty S."/>
</authorList>
<dbReference type="PubMed" id="16777713"/>
<dbReference type="DOI" id="10.1080/10799890600637506"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Mol. Pharmacol." volume="69" first="1413" last="1420">
<title>A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity.</title>
<authorList>
<person name="Takezawa R."/>
<person name="Cheng H."/>
<person name="Beck A."/>
<person name="Ishikawa J."/>
<person name="Launay P."/>
<person name="Kubota H."/>
<person name="Kinet J.-P."/>
<person name="Fleig A."/>
<person name="Yamada T."/>
<person name="Penner R."/>
</authorList>
<dbReference type="PubMed" id="16407466"/>
<dbReference type="DOI" id="10.1124/mol.105.021154"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="391" first="806" last="811">
<title>Cloning and characterization of rat transient receptor potential-melastatin 4 (TRPM4).</title>
<authorList>
<person name="Yoo J.C."/>
<person name="Yarishkin O.V."/>
<person name="Hwang E.M."/>
<person name="Kim E."/>
<person name="Kim D.G."/>
<person name="Park N."/>
<person name="Hong S.G."/>
<person name="Park J.Y."/>
</authorList>
<dbReference type="PubMed" id="19945433"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.11.142"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="J. Cell. Physiol." volume="226" first="103" last="109">
<title>TRPM4 enhances cell proliferation through up-regulation of the beta-catenin signaling pathway.</title>
<authorList>
<person name="Armisen R."/>
<person name="Marcelain K."/>
<person name="Simon F."/>
<person name="Tapia J.C."/>
<person name="Toro J."/>
<person name="Quest A.F."/>
<person name="Stutzin A."/>
</authorList>
<dbReference type="PubMed" id="20625999"/>
<dbReference type="DOI" id="10.1002/jcp.22310"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="J. Immunol." volume="185" first="2836" last="2846">
<title>Trpm4 differentially regulates Th1 and th2 function by altering calcium signaling and NFAT localization.</title>
<authorList>
<person name="Weber K.S."/>
<person name="Hildner K."/>
<person name="Murphy K.M."/>
<person name="Allen P.M."/>
</authorList>
<dbReference type="PubMed" id="20656926"/>
<dbReference type="DOI" id="10.4049/jimmunol.1000880"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23" evidence="1">
<citation type="journal article" date="2017" name="Nature" volume="552" first="200" last="204">
<title>Electron cryo-microscopy structure of a human TRPM4 channel.</title>
<authorList>
<person name="Winkler P.A."/>
<person name="Huang Y."/>
<person name="Sun W."/>
<person name="Du J."/>
<person name="Lu W."/>
</authorList>
<dbReference type="PubMed" id="29211723"/>
<dbReference type="DOI" id="10.1038/nature24674"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.80 ANGSTROMS) IN COMPLEX WITH CALCIUM</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
</reference>
<reference key="24" evidence="2 3">
<citation type="journal article" date="2018" name="Science" volume="359" first="228" last="232">
<title>Structure of the human TRPM4 ion channel in a lipid nanodisc.</title>
<authorList>
<person name="Autzen H.E."/>
<person name="Myasnikov A.G."/>
<person name="Campbell M.G."/>
<person name="Asarnow D."/>
<person name="Julius D."/>
<person name="Cheng Y."/>
</authorList>
<dbReference type="PubMed" id="29217581"/>
<dbReference type="DOI" id="10.1126/science.aar4510"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) IN COMPLEX WITH CALCIUM</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>TOPOLOGY</scope>
<scope>GLYCOSYLATION AT ASN-992</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Clin. Invest." volume="119" first="2737" last="2744">
<title>Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I.</title>
<authorList>
<person name="Kruse M."/>
<person name="Schulze-Bahr E."/>
<person name="Corfield V."/>
<person name="Beckmann A."/>
<person name="Stallmeyer B."/>
<person name="Kurtbay G."/>
<person name="Ohmert I."/>
<person name="Schulze-Bahr E."/>
<person name="Brink P."/>
<person name="Pongs O."/>
</authorList>
<dbReference type="PubMed" id="19726882"/>
<dbReference type="DOI" id="10.1172/jci38292"/>
</citation>
<scope>VARIANT PFHB1B LYS-7</scope>
<scope>CHARACTERIZATION OF VARIANT PFHB1B LYS-7</scope>
<scope>SUMOYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Circ. Cardiovasc. Genet." volume="3" first="374" last="385">
<title>Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease.</title>
<authorList>
<person name="Liu H."/>
<person name="El Zein L."/>
<person name="Kruse M."/>
<person name="Guinamard R."/>
<person name="Beckmann A."/>
<person name="Bozio A."/>
<person name="Kurtbay G."/>
<person name="Megarbane A."/>
<person name="Ohmert I."/>
<person name="Blaysat G."/>
<person name="Villain E."/>
<person name="Pongs O."/>
<person name="Bouvagnet P."/>
</authorList>
<dbReference type="PubMed" id="20562447"/>
<dbReference type="DOI" id="10.1161/circgenetics.109.930867"/>
</citation>
<scope>VARIANTS PFHB1B TRP-164; THR-432 AND ASP-844</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="109" last="117">
<title>Mutational spectrum in the Ca(2+) -activated cation channel gene TRPM4 in patients with cardiac conductance disturbances.</title>
<authorList>
<person name="Stallmeyer B."/>
<person name="Zumhagen S."/>
<person name="Denjoy I."/>
<person name="Duthoit G."/>
<person name="Hebert J.L."/>
<person name="Ferrer X."/>
<person name="Maugenre S."/>
<person name="Schmitz W."/>
<person name="Kirchhefer U."/>
<person name="Schulze-Bahr E."/>
<person name="Guicheney P."/>
<person name="Schulze-Bahr E."/>
</authorList>
<dbReference type="PubMed" id="21887725"/>
<dbReference type="DOI" id="10.1002/humu.21599"/>
</citation>
<scope>VARIANTS PFHB1B HIS-131; ARG-293; THR-432; SER-582; HIS-790; ASP-844; ARG-914 AND SER-970</scope>
<scope>VARIANTS THR-101; CYS-103; HIS-252; LYS-487 DEL; ALA-561; ARG-854 AND LEU-1204</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2019" name="J. Invest. Dermatol." volume="139" first="1089" last="1097">
<title>Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia.</title>
<authorList>
<person name="Wang H."/>
<person name="Xu Z."/>
<person name="Lee B.H."/>
<person name="Vu S."/>
<person name="Hu L."/>
<person name="Lee M."/>
<person name="Bu D."/>
<person name="Cao X."/>
<person name="Hwang S."/>
<person name="Yang Y."/>
<person name="Zheng J."/>
<person name="Lin Z."/>
</authorList>
<dbReference type="PubMed" id="30528822"/>
<dbReference type="DOI" id="10.1016/j.jid.2018.10.044"/>
</citation>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN EKVP6</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS EKVP6 MET-1033 AND THR-1040</scope>
<scope>CHARACTERIZATION OF VARIANTS EKVP6 MET-1033 AND THR-1040</scope>
</reference>
<comment type="function">
<text evidence="6 7 8 9 10 11 12 13 14 15 16 17 18 20 24 25 27 29">Calcium-activated non selective (CAN) cation channel that mediates membrane depolarization (PubMed:12015988, PubMed:29211723, PubMed:30528822). While it is activated by increase in intracellular Ca(2+), it is impermeable to it (PubMed:12015988). Mediates transport of monovalent cations (Na(+) &gt; K(+) &gt; Cs(+) &gt; Li(+)), leading to depolarize the membrane. It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, endocrine pancreas cells, kidney epithelial cells, cochlea hair cells etc. Participates in T-cell activation by modulating Ca(2+) oscillations after T lymphocyte activation, which is required for NFAT-dependent IL2 production. Involved in myogenic constriction of cerebral arteries. Controls insulin secretion in pancreatic beta-cells. May also be involved in pacemaking or could cause irregular electrical activity under conditions of Ca(2+) overload. Affects T-helper 1 (Th1) and T-helper 2 (Th2) cell motility and cytokine production through differential regulation of calcium signaling and NFATC1 localization. Enhances cell proliferation through up-regulation of the beta-catenin signaling pathway. Plays a role in keratinocyte differentiation (PubMed:30528822).</text>
</comment>
<comment type="activity regulation">
<text evidence="9 11 14 16 17 18 27">Gating is voltage-dependent and repressed by decavanadate (PubMed:15331675, PubMed:29211723). Calmodulin-binding confers the Ca(2+) sensitivity (PubMed:15590641). ATP is able to restore Ca(2+) sensitivity after desensitization (PubMed:15590641). ATP inhibits channel activity (PubMed:15331675, PubMed:14758478, PubMed:29211723). Phosphatidylinositol 4,5-bisphosphate (PIP2)-binding strongly enhances activity, by increasing the channel's Ca(2+) sensitivity and shifting its voltage dependence of activation towards negative potentials (PubMed:16186107, PubMed:16424899). Activity is also enhanced by 3,5-bis(trifluoromethyl)pyrazole derivative (BTP2) (PubMed:16407466).</text>
</comment>
<comment type="subunit">
<text evidence="27 28 33">Homotetramer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-717048">
<id>P60903</id>
<label>S100A10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-701862">
<id>P31949</id>
<label>S100A11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-752230">
<id>P29034</id>
<label>S100A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-1044747">
<id>P33764</id>
<label>S100A3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-717058">
<id>P26447</id>
<label>S100A4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-7211732">
<id>P33763</id>
<label>S100A5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-352877">
<id>P06703</id>
<label>S100A6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11723041">
<id>Q8TD43</id>
</interactant>
<interactant intactId="EBI-355281">
<id>P05109</id>
<label>S100A8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-20594601">
<id>Q8TD43-1</id>
</interactant>
<interactant intactId="EBI-20594601">
<id>Q8TD43-1</id>
<label>TRPM4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="7 11 14 22 27">Cell membrane</location>
<topology evidence="27 28">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="22">Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22">Golgi apparatus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="6">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8TD43-1</id>
<name>1</name>
<name>TRPM4b</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8TD43-2</id>
<name>2</name>
<name>TRPM4a</name>
<sequence type="described" ref="VSP_021442"/>
</isoform>
<isoform>
<id>Q8TD43-3</id>
<name>3</name>
<name>TRPM4c</name>
<sequence type="described" ref="VSP_021443"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="6 7 8 12 19 21 25 29">Widely expressed with a high expression in intestine and prostate. In brain, it is both expressed in whole cerebral arteries and isolated vascular smooth muscle cells. Prominently expressed in Purkinje fibers. Expressed at higher levels in T-helper 2 (Th2) cells as compared to T-helper 1 (Th1) cells. Expressed in keratocytes (PubMed:30528822).</text>
</comment>
<comment type="PTM">
<text evidence="14">Phosphorylation by PKC leads to increase the sensitivity to Ca(2+).</text>
</comment>
<comment type="PTM">
<text evidence="21">Sumoylated. Desumoylated by SENP1.</text>
</comment>
<comment type="disease" evidence="21 23 26">
<disease id="DI-02825">
<name>Progressive familial heart block 1B</name>
<acronym>PFHB1B</acronym>
<description>A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.</description>
<dbReference type="MIM" id="604559"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="29">
<disease id="DI-05634">
<name>Erythrokeratodermia variabilis et progressiva 6</name>
<acronym>EKVP6</acronym>
<description>A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. EKVP6 inheritance is autosomal dominant.</description>
<dbReference type="MIM" id="618531"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the transient receptor (TC 1.A.4) family. LTrpC subfamily. TRPM4 sub-subfamily.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="BAA90907" version="1"/>
</conflict>
<text>Truncated C-terminus.</text>
</comment>
<dbReference type="EMBL" id="AY046396">
<property type="protein sequence ID" value="AAL02142.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF497623">
<property type="protein sequence ID" value="AAM18083.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY297044">
<property type="protein sequence ID" value="AAP44473.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY297045">
<property type="protein sequence ID" value="AAP44474.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY297046">
<property type="protein sequence ID" value="AAP44475.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ575813">
<property type="protein sequence ID" value="CAE05941.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000048">
<property type="protein sequence ID" value="BAA90907.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292862">
<property type="protein sequence ID" value="BAF85551.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132727">
<property type="protein sequence ID" value="AAI32728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33073.1">
<molecule id="Q8TD43-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56098.1">
<molecule id="Q8TD43-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001182156.1">
<molecule id="Q8TD43-3"/>
<property type="nucleotide sequence ID" value="NM_001195227.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001308212.1">
<molecule id="Q8TD43-2"/>
<property type="nucleotide sequence ID" value="NM_001321283.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_060106.2">
<molecule id="Q8TD43-1"/>
<property type="nucleotide sequence ID" value="NM_017636.3"/>
</dbReference>
<dbReference type="PDB" id="5WP6">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="A/B/C/D=1-1214"/>
</dbReference>
<dbReference type="PDB" id="6BQR">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D=75-1168"/>
</dbReference>
<dbReference type="PDB" id="6BQV">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C/D=2-1214"/>
</dbReference>
<dbReference type="PDB" id="6BWI">
<property type="method" value="EM"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A/B/C/D=395-1176"/>
</dbReference>
<dbReference type="PDBsum" id="5WP6"/>
<dbReference type="PDBsum" id="6BQR"/>
<dbReference type="PDBsum" id="6BQV"/>
<dbReference type="PDBsum" id="6BWI"/>
<dbReference type="SMR" id="Q8TD43"/>
<dbReference type="BioGRID" id="120154">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="IntAct" id="Q8TD43">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="Q8TD43"/>
<dbReference type="STRING" id="9606.ENSP00000252826"/>
<dbReference type="ChEMBL" id="CHEMBL1628469"/>
<dbReference type="DrugBank" id="DB01016">
<property type="generic name" value="Glyburide"/>
</dbReference>
<dbReference type="DrugCentral" id="Q8TD43"/>
<dbReference type="GuidetoPHARMACOLOGY" id="496"/>
<dbReference type="TCDB" id="1.A.4.5.4">
<property type="family name" value="the transient receptor potential ca(2+) channel (trp-cc) family"/>
</dbReference>
<dbReference type="GlyGen" id="Q8TD43">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q8TD43"/>
<dbReference type="PhosphoSitePlus" id="Q8TD43"/>
<dbReference type="BioMuta" id="TRPM4"/>
<dbReference type="DMDM" id="74715868"/>
<dbReference type="EPD" id="Q8TD43"/>
<dbReference type="jPOST" id="Q8TD43"/>
<dbReference type="MassIVE" id="Q8TD43"/>
<dbReference type="MaxQB" id="Q8TD43"/>
<dbReference type="PaxDb" id="Q8TD43"/>
<dbReference type="PeptideAtlas" id="Q8TD43"/>
<dbReference type="PRIDE" id="Q8TD43"/>
<dbReference type="ProteomicsDB" id="74233">
<molecule id="Q8TD43-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="74234">
<molecule id="Q8TD43-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="74235">
<molecule id="Q8TD43-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="31943">
<property type="antibodies" value="286 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000252826">
<molecule id="Q8TD43-1"/>
<property type="protein sequence ID" value="ENSP00000252826"/>
<property type="gene ID" value="ENSG00000130529"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000427978">
<molecule id="Q8TD43-3"/>
<property type="protein sequence ID" value="ENSP00000407492"/>
<property type="gene ID" value="ENSG00000130529"/>
</dbReference>
<dbReference type="GeneID" id="54795"/>
<dbReference type="KEGG" id="hsa:54795"/>
<dbReference type="UCSC" id="uc002pmw.4">
<molecule id="Q8TD43-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="54795"/>
<dbReference type="DisGeNET" id="54795"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000130529.15"/>
<dbReference type="GeneCards" id="TRPM4"/>
<dbReference type="GeneReviews" id="TRPM4"/>
<dbReference type="HGNC" id="HGNC:17993">
<property type="gene designation" value="TRPM4"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000130529">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TRPM4"/>
<dbReference type="MIM" id="604559">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606936">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618531">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8TD43"/>
<dbReference type="OpenTargets" id="ENSG00000130529"/>
<dbReference type="Orphanet" id="130">
<property type="disease" value="Brugada syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="871">
<property type="disease" value="Familial progressive cardiac conduction defect"/>
</dbReference>
<dbReference type="Orphanet" id="316">
<property type="disease" value="Progressive symmetric erythrokeratodermia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA38272"/>
<dbReference type="eggNOG" id="KOG3614">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158693"/>
<dbReference type="HOGENOM" id="CLU_001390_0_1_1"/>
<dbReference type="InParanoid" id="Q8TD43"/>
<dbReference type="KO" id="K04979"/>
<dbReference type="OMA" id="FPATYYM"/>
<dbReference type="OrthoDB" id="738147at2759"/>
<dbReference type="PhylomeDB" id="Q8TD43"/>
<dbReference type="TreeFam" id="TF314204"/>
<dbReference type="PathwayCommons" id="Q8TD43"/>
<dbReference type="Reactome" id="R-HSA-3295583">
<property type="pathway name" value="TRP channels"/>
</dbReference>
<dbReference type="SIGNOR" id="Q8TD43"/>
<dbReference type="BioGRID-ORCS" id="54795">
<property type="hits" value="4 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TRPM4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TRPM4"/>
<dbReference type="GenomeRNAi" id="54795"/>
<dbReference type="Pharos" id="Q8TD43">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8TD43"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q8TD43">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130529">
<property type="expression patterns" value="Expressed in adult mammalian kidney and 170 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8TD43">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8TD43">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034706">
<property type="term" value="C:sodium channel complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0089717">
<property type="term" value="C:spanning component of membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044214">
<property type="term" value="C:spanning component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005227">
<property type="term" value="F:calcium activated cation channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005262">
<property type="term" value="F:calcium channel activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070588">
<property type="term" value="P:calcium ion transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019722">
<property type="term" value="P:calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071318">
<property type="term" value="P:cellular response to ATP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002407">
<property type="term" value="P:dendritic cell chemotaxis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098662">
<property type="term" value="P:inorganic cation transmembrane transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0086045">
<property type="term" value="P:membrane depolarization during AV node cell action potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0086048">
<property type="term" value="P:membrane depolarization during bundle of His cell action potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0086047">
<property type="term" value="P:membrane depolarization during Purkinje myocyte cell action potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030502">
<property type="term" value="P:negative regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045668">
<property type="term" value="P:negative regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904179">
<property type="term" value="P:positive regulation of adipose tissue development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903949">
<property type="term" value="P:positive regulation of atrial cardiac muscle cell action potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045600">
<property type="term" value="P:positive regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010460">
<property type="term" value="P:positive regulation of heart rate"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035774">
<property type="term" value="P:positive regulation of insulin secretion involved in cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904199">
<property type="term" value="P:positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0086091">
<property type="term" value="P:regulation of heart rate by cardiac conduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002724">
<property type="term" value="P:regulation of T cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098911">
<property type="term" value="P:regulation of ventricular cardiac muscle cell action potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098719">
<property type="term" value="P:sodium ion import across plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042310">
<property type="term" value="P:vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="InterPro" id="IPR005821">
<property type="entry name" value="Ion_trans_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029581">
<property type="entry name" value="TRPM4"/>
</dbReference>
<dbReference type="InterPro" id="IPR041491">
<property type="entry name" value="TRPM_SLOG"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13800:SF6">
<property type="entry name" value="PTHR13800:SF6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00520">
<property type="entry name" value="Ion_trans"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18139">
<property type="entry name" value="LSDAT_euk"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0112">Calmodulin-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-1007">Palmoplantar keratoderma</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transient receptor potential cation channel subfamily M member 4" id="PRO_0000259529">
<location>
<begin position="1"/>
<end position="1214"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="27 28">
<location>
<begin position="1"/>
<end position="782"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27 28">
<location>
<begin position="783"/>
<end position="803"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="27 28">
<location>
<begin position="804"/>
<end position="814"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27 28">
<location>
<begin position="815"/>
<end position="835"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="27 28">
<location>
<begin position="836"/>
<end position="863"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27 28">
<location>
<begin position="864"/>
<end position="884"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="27 28">
<location>
<begin position="885"/>
<end position="886"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27 28">
<location>
<begin position="887"/>
<end position="910"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="27 28">
<location>
<begin position="911"/>
<end position="930"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27 28">
<location>
<begin position="931"/>
<end position="951"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="27 28">
<location>
<begin position="952"/>
<end position="963"/>
</location>
</feature>
<feature type="intramembrane region" description="Pore-forming" evidence="27 28">
<location>
<begin position="964"/>
<end position="984"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="27 28">
<location>
<begin position="985"/>
<end position="1019"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27 28">
<location>
<begin position="1020"/>
<end position="1040"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="27 28">
<location>
<begin position="1041"/>
<end position="1214"/>
</location>
</feature>
<feature type="region of interest" description="Calmodulin-binding">
<location>
<begin position="1076"/>
<end position="1176"/>
</location>
</feature>
<feature type="region of interest" description="Mediates modulation by decavanadate and PIP2-binding" evidence="18">
<location>
<begin position="1136"/>
<end position="1141"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="5">
<location>
<begin position="1134"/>
<end position="1187"/>
</location>
</feature>
<feature type="short sequence motif" description="Selectivity filter" evidence="35">
<location>
<begin position="975"/>
<end position="977"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 28">
<location>
<position position="828"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 28">
<location>
<position position="831"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 28">
<location>
<position position="865"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 36">
<location>
<position position="868"/>
</location>
</feature>
<feature type="binding site" description="ATP; shared with neighboring subunit" evidence="4">
<location>
<position position="171"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="4">
<location>
<position position="421"/>
</location>
</feature>
<feature type="binding site" description="ATP; via carbonyl oxygen" evidence="4">
<location>
<position position="448"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC" evidence="34">
<location>
<position position="1145"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC" evidence="34">
<location>
<position position="1152"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="28">
<location>
<position position="992"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 28">
<location>
<begin position="993"/>
<end position="1011"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021442" evidence="30 31">
<location>
<begin position="1"/>
<end position="174"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_021443" evidence="31">
<location>
<begin position="738"/>
<end position="882"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; attenuated desumoylation of TRPM4 resulting in constitutive sumoylation of the channel leading to impaired endocytosis and elevated channel density at the cell surface; dbSNP:rs267607142." id="VAR_064042" evidence="21">
<original>E</original>
<variation>K</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs113984787." id="VAR_066761" evidence="26">
<original>A</original>
<variation>T</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs144781529." id="VAR_066762" evidence="26">
<original>Y</original>
<variation>C</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; incomplete right bundle-branch block; dbSNP:rs172146854." id="VAR_066763" evidence="26">
<original>Q</original>
<variation>H</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; dbSNP:rs387907216." id="VAR_066764" evidence="23">
<original>R</original>
<variation>W</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs146564314." id="VAR_066765" evidence="26">
<original>R</original>
<variation>H</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; right bundle-branch block; dbSNP:rs172147855." id="VAR_066766" evidence="26">
<original>Q</original>
<variation>R</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; atrioventricular block; dbSNP:rs201907325." id="VAR_066767" evidence="23 26">
<original>A</original>
<variation>T</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_066768">
<location>
<begin position="487"/>
<end position="498"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56355369." id="VAR_066769" evidence="26">
<original>D</original>
<variation>A</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; atrioventricular block; dbSNP:rs172149856." id="VAR_066770" evidence="26">
<original>G</original>
<variation>S</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; atrioventricular block; dbSNP:rs172150857." id="VAR_066771" evidence="26">
<original>Y</original>
<variation>H</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; right bundle-branch block; dbSNP:rs200038418." id="VAR_066772" evidence="23 26">
<original>G</original>
<variation>D</variation>
<location>
<position position="844"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs172155862." id="VAR_066773" evidence="26">
<original>Q</original>
<variation>R</variation>
<location>
<position position="854"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; atrioventricular block; dbSNP:rs172151858." id="VAR_066774" evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="914"/>
</location>
</feature>
<feature type="sequence variant" description="In PFHB1B; incomplete right bundle-branch block; dbSNP:rs172152859." id="VAR_066775" evidence="26">
<original>P</original>
<variation>S</variation>
<location>
<position position="970"/>
</location>
</feature>
<feature type="sequence variant" description="In EKVP6; increased calcium activated cation channel activity; increased keratinocytes proliferation and differentiation; no effect on localization at cell membrane." id="VAR_083166" evidence="29">
<original>I</original>
<variation>M</variation>
<location>
<position position="1033"/>
</location>
</feature>
<feature type="sequence variant" description="In EKVP6; increased calcium activated cation channel activity; increased keratinocytes proliferation and differentiation; no effect on localization at cell membrane; dbSNP:rs1369949906." id="VAR_083167" evidence="29">
<original>I</original>
<variation>T</variation>
<location>
<position position="1040"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs150391806." id="VAR_066776" evidence="26">
<original>P</original>
<variation>L</variation>
<location>
<position position="1204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to restore sensitivity to Ca(2+) after desensitization." evidence="14">
<original>L</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="14">
<original>I</original>
<variation>N</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="14">
<original>D</original>
<variation>N</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="14">
<original>G</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to restore sensitivity to Ca(2+) after desensitization." evidence="14">
<original>G</original>
<variation>A</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="14">
<original>R</original>
<variation>A</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="mutagenesis site" description="Alters the monovalent cation permeability sequence and results in a pore with moderate Ca(2+) permeability." evidence="15">
<original>Q</original>
<variation>E</variation>
<location>
<position position="977"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces a functional channel that combines the gating hallmarks of TRPM4 (activation by Ca(2+)) with TRPV6-like sensitivity to block by extracellular Ca(2+) and Mg(2+) as well as Ca(2+) permeation." evidence="15">
<original>EDMDVA</original>
<variation>TIIDGP</variation>
<location>
<begin position="981"/>
<end position="986"/>
</location>
</feature>
<feature type="mutagenesis site" description="Results in a channel with normal permeability properties but with a reduced sensitivity to block by intracellular spermine." evidence="15">
<original>E</original>
<variation>A</variation>
<location>
<position position="981"/>
</location>
</feature>
<feature type="mutagenesis site" description="Results in a functional channel that exhibits extremely fast desensitization, possibly indicating destabilization of the pore." evidence="15">
<original>D</original>
<variation>A</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="mutagenesis site" description="Results in a non-functional channel with a dominant negative phenotype." evidence="15">
<original>D</original>
<variation>A</variation>
<location>
<position position="984"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect PIP2-binding." evidence="18">
<original>K</original>
<variation>Q</variation>
<location>
<position position="1059"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect PIP2-binding." evidence="18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1072"/>
</location>
</feature>
<feature type="mutagenesis site" description="Results in a channel with very rapid desensitization and highly reduced sensitivity to PIP2." evidence="18">
<location>
<begin position="1136"/>
<end position="1141"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases the sensitivity to Ca(2+)." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="1145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases the sensitivity to Ca(2+)." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="1152"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAA90907." ref="6" evidence="32">
<original>K</original>
<variation>E</variation>
<location>
<position position="1149"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAA90907." ref="6" evidence="32">
<original>P</original>
<variation>L</variation>
<location>
<position position="1207"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAA90907." ref="6" evidence="32">
<original>P</original>
<variation>H</variation>
<location>
<position position="1210"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAA90907." ref="6" evidence="32">
<original>D</original>
<variation>E</variation>
<location>
<position position="1214"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="88"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="100"/>
<end position="107"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="118"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="132"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="142"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="152"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="158"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="162"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="185"/>
<end position="187"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="191"/>
<end position="193"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="202"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="230"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="238"/>
<end position="240"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="245"/>
<end position="259"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="260"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="268"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="273"/>
<end position="277"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="282"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="298"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="308"/>
<end position="315"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="319"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="331"/>
<end position="338"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="344"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="359"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="370"/>
<end position="372"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="373"/>
<end position="385"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="395"/>
<end position="397"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="398"/>
<end position="402"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="406"/>
<end position="414"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="415"/>
<end position="417"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="422"/>
<end position="434"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="438"/>
<end position="446"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="451"/>
<end position="454"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="457"/>
<end position="465"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="469"/>
<end position="473"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="474"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="504"/>
<end position="509"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="560"/>
<end position="568"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="572"/>
<end position="578"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="579"/>
<end position="581"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="585"/>
<end position="601"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="608"/>
<end position="633"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="635"/>
<end position="642"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="648"/>
<end position="651"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="654"/>
<end position="660"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="664"/>
<end position="667"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="670"/>
<end position="680"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="681"/>
<end position="683"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="690"/>
<end position="697"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="700"/>
<end position="704"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="705"/>
<end position="708"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="768"/>
<end position="776"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="779"/>
<end position="803"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="807"/>
<end position="809"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="812"/>
<end position="829"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="830"/>
<end position="834"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="852"/>
<end position="859"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="863"/>
<end position="883"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="888"/>
<end position="909"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="914"/>
<end position="916"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="917"/>
<end position="920"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="921"/>
<end position="926"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="927"/>
<end position="951"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="959"/>
<end position="965"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="968"/>
<end position="972"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="973"/>
<end position="975"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="980"/>
<end position="983"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="985"/>
<end position="987"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="995"/>
<end position="998"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1005"/>
<end position="1008"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1017"/>
<end position="1030"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1031"/>
<end position="1033"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1034"/>
<end position="1070"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1080"/>
<end position="1086"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1087"/>
<end position="1093"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1115"/>
<end position="1141"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1144"/>
<end position="1166"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1168"/>
<end position="1174"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WP6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6BQR"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6BQV"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q7TN37"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11535825"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12015988"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12799367"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14758478"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15121803"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15331675"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15472118"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15550671"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590641"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15845551"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16186107"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16407466"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16424899"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16777713"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16806463"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19726882"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19945433"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20562447"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20625999"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20656926"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21887725"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29211723"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29217581"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30528822"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11535825"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12842017"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12015988"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15590641"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="29211723"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="29217581"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:17993"/>
</source>
</evidence>
<sequence length="1214" mass="134301" checksum="76ADA452690ED8F5" modified="2002-06-01" version="1">MVVPEKEQSWIPKIFKKKTCTTFIVDSTDPGGTLCQCGRPRTAHPAVAMEDAFGAAVVTVWDSDAHTTEKPTDAYGELDFTGAGRKHSNFLRLSDRTDPAAVYSLVTRTWGFRAPNLVVSVLGGSGGPVLQTWLQDLLRRGLVRAAQSTGAWIVTGGLHTGIGRHVGVAVRDHQMASTGGTKVVAMGVAPWGVVRNRDTLINPKGSFPARYRWRGDPEDGVQFPLDYNYSAFFLVDDGTHGCLGGENRFRLRLESYISQQKTGVGGTGIDIPVLLLLIDGDEKMLTRIENATQAQLPCLLVAGSGGAADCLAETLEDTLAPGSGGARQGEARDRIRRFFPKGDLEVLQAQVERIMTRKELLTVYSSEDGSEEFETIVLKALVKACGSSEASAYLDELRLAVAWNRVDIAQSELFRGDIQWRSFHLEASLMDALLNDRPEFVRLLISHGLSLGHFLTPMRLAQLYSAAPSNSLIRNLLDQASHSAGTKAPALKGGAAELRPPDVGHVLRMLLGKMCAPRYPSGGAWDPHPGQGFGESMYLLSDKATSPLSLDAGLGQAPWSDLLLWALLLNRAQMAMYFWEMGSNAVSSALGACLLLRVMARLEPDAEEAARRKDLAFKFEGMGVDLFGECYRSSEVRAARLLLRRCPLWGDATCLQLAMQADARAFFAQDGVQSLLTQKWWGDMASTTPIWALVLAFFCPPLIYTRLITFRKSEEEPTREELEFDMDSVINGEGPVGTADPAEKTPLGVPRQSGRPGCCGGRCGGRRCLRRWFHFWGAPVTIFMGNVVSYLLFLLLFSRVLLVDFQPAPPGSLELLLYFWAFTLLCEELRQGLSGGGGSLASGGPGPGHASLSQRLRLYLADSWNQCDLVALTCFLLGVGCRLTPGLYHLGRTVLCIDFMVFTVRLLHIFTVNKQLGPKIVIVSKMMKDVFFFLFFLGVWLVAYGVATEGLLRPRDSDFPSILRRVFYRPYLQIFGQIPQEDMDVALMEHSNCSSEPGFWAHPPGAQAGTCVSQYANWLVVLLLVIFLLVANILLVNLLIAMFSYTFGKVQGNSDLYWKAQRYRLIREFHSRPALAPPFIVISHLRLLLRQLCRRPRSPQPSSPALEHFRVYLSKEAERKLLTWESVHKENFLLARARDKRESDSERLKRTSQKVDLALKQLGHIREYEQRLKVLEREVQQCSRVLGWVAEALSRSALLPPGGPPPPDLPGSKD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

